Instrumento Inactivo

Acciones Amylin Pharmaceuticals LLC

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Amylin Pharmaceuticals, Inc. : Bristol-Myers Squibb and AstraZeneca Complete Expansion of Diabetes Alliance Through Bristol-Myers Squibb's Acquisition of Amylin	09/08/12
Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading	02/08/12
BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion	16/07/12
GlaxoSmithKline plc : Exclusive: GSK set for Human Genome takeover - sources	16/07/12
GlaxoSmithKline plc : GSK in weekend talks to buy Human Genome: sources	15/07/12

Sector

	Varia. 1 de ene.	Capi.
CSL LIMITED	-3,26 %	90,45 mil M
SAMSUNG BIOLOGICS CO.,LTD.	+3,95 %	41,45 mil M
BIOGEN INC.	-10,51 %	33,57 mil M
UCB	+60,58 %	25,73 mil M
BIOMARIN PHARMACEUTICAL INC.	-20,09 %	14,73 mil M
INCYTE CORPORATION	-8,92 %	12,82 mil M
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11,46 %	11,7 mil M
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,05 %	11,44 mil M
SWEDISH ORPHAN BIOVITRUM AB	+5,17 %	8792,23 M